Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SMMT
#666
Summit Therapeutics Inc. Common Stock
20.850
0
USD
+4.09%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+4.09%
Mudança mensal
+29.66%
Mudança em 6 meses
+4.98%
Mudança anual
+4.98%
Fechamento anterior
20.030
0
Abrir
20.850
0
Bid
Ask
Mínimo
20.850
0
High
20.850
0
Volume
80
Mercados
Ações
Cuidados de saúde
SMMT
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
82.92 M
98.12 M
697.69 M
701.7 M
737.68 M
775.37 M
—
Valuation ratios
Enterprise value
323.29 M
192.16 M
3.14 B
1.89 B
13.07 B
13.34 B
58.1 B
Price to earnings ratio
-6.18
-2.8
-12.2
-2.67
-57.56
-12.15
-106.61
Price to sales ratio
379.96
137.16
1 371.18
—
—
-21.44 K
-242.26 K
Price to cash flow ratio
-6.79
-3.42
-23.25
-21.31
-90.23
-40.5
-253.14
Price to book ratio
4.11
2.98
7.63
21.06
32.98
19.85
53.73
Enterprise value to EBITDA ratio
-4.56
-1.82
-36.83
-2.91
-57.08
-12.1
-103.67
Profitability ratios
Return on assets %
-0.51
-0.78
-0.12
-3.03
-0.51
-1.44
-3.09
Return on equity %
-0.66
-1.06
-0.62
-7.91
-0.57
-1.64
-3.9
Return on invested capital %
-824.67
-1 235.4
-172.33
-1 492.71
-3 507.86
-10.84 K
—
Gross margin %
100
100
100
—
—
100
400
Operating margin %
-6 185.23
-4 764.29
-10.23 K
—
—
179.51 K
458.89 K
EBITDA margin %
-8 250.35
-5 848.92
-12.09 K
—
—
180.64 K
458.64 K
Net margin %
-6 127.56
-4 897.84
-11.17 K
—
—
176.98 K
456.03 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
4.41
3.8
16.93
9.3
10.15
9.87
29.42
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.01
0.02
0
0
0
-0
-0
Solvency ratios
Debt to assets ratio
—
—
—
0.52
0.02
—
—
Debt to equity ratio
—
—
—
1.37
0.02
—
—
Long term debt to total assets ratio
—
—
—
0.49
0
—
—
Long term debt to total equity ratio
—
—
—
1.29
0
—
—
Per share metrics
Operating cash flow per share
-0.69
-0.79
-0.22
-0.12
-0.2
-0.43
-0.43
EBIT per share
-1.04
-1.16
-0.45
-0.99
-0.31
-1.46
-1.47
EBITDA per share
-1.02
-1.15
-0.44
-0.99
-0.32
-1.47
-1.48
Total debt per share
—
—
—
0.17
0.01
—
—
Cash per share
0.96
0.78
1.8
0.3
0.57
0.95
2.17
Net current asset value per share
1.26
1.05
3.4
0.31
0.59
0.96
2.21
Tangible book value per share
0.95
0.77
0.65
0.12
0.54
0.88
1.94
Working capital per share
0.97
0.78
3.2
0.27
0.53
0.87
1.9
Book value per share
1.14
0.9
0.66
0.13
0.54
0.88
1.96
Notícias
Stifel inicia cobertura da Summit Therapeutics com recomendação de compra
Cantor Fitzgerald mantém classificação acima da média para ações da Summit Therapeutics
Why Is Ironwood (IRWD) Down 13.9% Since Last Earnings Report?
Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)
Jefferies rebaixa ações da Summit Therapeutics devido a riscos de testes clínicos
Jefferies downgrades Summit Therapeutics stock rating on trial risks
Micron and Facebook among market cap stock movers on Friday
Summit Therapeutics na Conferência Citizens Life Sciences: insights estratégicos sobre ivonescimab
Summit Therapeutics at The Citizens Life Sciences Conference: Strategic Insights on Ivonescimab
Summit Therapeutics Inc. (SMMT) Presents at The Citizens Life Sciences Conference 2026 Transcript
Summit Therapeutics apresenta foco estratégico no ivonesimab na conferência da TD Cowen
Summit Therapeutics at TD Cowen Conference: Strategic Focus on Ivonesimab